NDC00536-1232-01 — ASPIRIN DELAYED-RELEASE TABLETS

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00536-1232-01: ASPIRIN DELAYED-RELEASE TABLETS.

ASPIRIN DELAYED-RELEASE TABLETS. Key specifications include administration: ORAL, features_provided: ENTERIC COATED, long_action_method: DELAYED RELEASE, primary_container_type: BOTTLE, protective_storage_feature: EXPIRATION DATED, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-502-3905, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00536-1232-01

NSN: 6505-01-502-3905
FSC: 6505 — Drugs and Biologicals
CAGE: 1LEZ0 — THE HARVARD DRUG GROUP, L.L.C. DBA THE HARVARD DRUG GROUP, L.L.C DIV MAJOR PHARMACEUTICALS & RUGBY LABORATORIES (USA)

SPECIFICATIONS

administration	ORAL
special_features	REGULAR STRENGTH; FOR TEMPORARY RELIEF OF MINOR ACHES, PAINS, AND INFLAMMATION OF ARTHRITIS AND RHEUMATISM, ANTIPLATELET; STORE AT CONTROLLED ROOM TEMPERATURE (59 TO 88 DERGREES F)
features_provided	ENTERIC COATED
long_action_method	DELAYED RELEASE
primary_container_type	BOTTLE
protective_storage_feature	EXPIRATION DATED
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	1
primary_container_content_quantity	100.000 TABLETS
active_medicament_medicinal_strength	325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	ASPIRIN TABLETS DELAYED RELEASE USP 325MG BT 100S
american_hospital_formulary_service_classification_number	280804
NSN	6505-01-502-3905

COMPONENT DIAGRAM

KEY FEATURES

•

LONG ACTION METHOD: DELAYED RELEASE

•

ADMINISTRATION: ORAL

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

FEATURES PROVIDED: ENTERIC COATED

•

PRIMARY CONTAINER TYPE: BOTTLE

•

PROTECTIVE STORAGE FEATURE: EXPIRATION DATED

TECHNICAL CHARACTERISTICS

LONG ACTION METHOD	DELAYED RELEASE
ADMINISTRATION	ORAL
PRIMARY CONTAINER CONTENT QUANTITY	100.000 TABLETS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
FEATURES PROVIDED	ENTERIC COATED
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	REGULAR STRENGTH; FOR TEMPORARY RELIEF OF MINOR ACHES, PAINS, AND INFLAMMATION OF ARTHRITIS AND RHEUMATISM, ANTIPLATELET; STORE AT CONTROLLED ROOM TEMPERATURE (59 TO 88 DERGREES F)
PROTECTIVE STORAGE FEATURE	EXPIRATION DATED
PART NAME ASSIGNED BY CONTROLLING AGENCY	ASPIRIN TABLETS DELAYED RELEASE USP 325MG BT 100S
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER	280804

SUBSTITUTES & CROSS-REFERENCES 2

02-1532Reference document

Same NSN cross-reference

Reference document — Secondary reference

6505NCM020936Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00536-1232-01?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00536-1232-01?

NDC00536-1232-01 is a ASPIRIN DELAYED-RELEASE TABLETS.

What parts can replace NDC00536-1232-01?

There are 2 known substitutes for NDC00536-1232-01: 02-1532, 6505NCM020936. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00536-1232-01?

NDC00536-1232-01 is cataloged in the U.S. Government catalog under NSN 6505-01-502-3905. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00536-1232-01 — ASPIRIN DELAYED-RELEASE TABLETS

Request a Quote — NDC00536-1232-01